Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2010

01-04-2010 | Article

Management of post-splenectomy patients in the Netherlands

Authors: A. J. J. Lammers, D. Veninga, M. J. M. H. Lombarts, J. B. L. Hoekstra, P. Speelman

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2010

Login to get access

Abstract

After splenectomy, patients are at increased risk of sepsis with considerable mortality. The risk of sepsis can be reduced by immunising these patients and by prescribing antibiotic prophylaxis. The purpose of our study was to determine compliance with the international standards for the management of splenectomised patients in the Netherlands by investigating: (i) vaccination rates, (ii) the prescription of antibiotics and (iii) information in discharge letters. A retrospective review of the medical records and discharge correspondence of 609 splenectomy patients from 1997 to 2008 was performed. Data were collected from 28 hospitals. Adherence to vaccination guidelines and the prescription of antibiotics were assessed. It was found that 85.4% of post-splenectomy patients received pneumococcal vaccination, 39.4% received Haemophilus influenzae type B and 32.3% received meningococcal group C vaccination. Also, 12.4% of patients were discharged on prophylactic antibiotics. In less than 25% of cases were adequate recommendations regarding post-splenectomy management given to the general practitioner (GP). In the Netherlands, compliance with recommendations for the management of patients after splenectomy is insufficient. Fifteen percent of patients do not receive vaccination against pneumococci and the majority of patients do not receive antibiotic prophylaxis. The development and implementation of a national guideline for splenectomised patients is urgently required.
Literature
1.
go back to reference Morris DH, Bullock FD (1919) The importance of the spleen in resistance to infection. Ann Surg 70:513–521CrossRefPubMed Morris DH, Bullock FD (1919) The importance of the spleen in resistance to infection. Ann Surg 70:513–521CrossRefPubMed
2.
3.
go back to reference Hosea SW, Brown EJ, Hamburger MI et al (1981) Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med 304:245–250PubMedCrossRef Hosea SW, Brown EJ, Hamburger MI et al (1981) Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med 304:245–250PubMedCrossRef
4.
go back to reference Huston JM, Ochani M, Rosas-Ballina M et al (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203:1623–1628CrossRefPubMed Huston JM, Ochani M, Rosas-Ballina M et al (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203:1623–1628CrossRefPubMed
5.
go back to reference Deodhar M, Kakkar N (2004) An audit of splenectomies in a teaching hospital in North India. Are postsplenectomy guidelines being complied with? J Clin Pathol 57:407–410CrossRefPubMed Deodhar M, Kakkar N (2004) An audit of splenectomies in a teaching hospital in North India. Are postsplenectomy guidelines being complied with? J Clin Pathol 57:407–410CrossRefPubMed
6.
go back to reference Newland A, Provan D, Myint S (2005) Preventing severe infection after splenectomy. BMJ 331:417–418CrossRefPubMed Newland A, Provan D, Myint S (2005) Preventing severe infection after splenectomy. BMJ 331:417–418CrossRefPubMed
7.
go back to reference Holdsworth RJ, Irving AD, Cuschieri A (1991) Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 78:1031–1038CrossRefPubMed Holdsworth RJ, Irving AD, Cuschieri A (1991) Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 78:1031–1038CrossRefPubMed
8.
go back to reference Waghorn DJ (2001) Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol 54:214–218CrossRefPubMed Waghorn DJ (2001) Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol 54:214–218CrossRefPubMed
9.
go back to reference Brigden ML, Pattullo A, Brown G (2000) Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist. Am J Hematol 65:25–29CrossRefPubMed Brigden ML, Pattullo A, Brown G (2000) Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist. Am J Hematol 65:25–29CrossRefPubMed
10.
go back to reference Styrt B (1990) Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med 88:33N–42NCrossRefPubMed Styrt B (1990) Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med 88:33N–42NCrossRefPubMed
11.
go back to reference Singer DB (1973) Postsplenectomy sepsis. Perspect Pediatr Pathol 1:285–311PubMed Singer DB (1973) Postsplenectomy sepsis. Perspect Pediatr Pathol 1:285–311PubMed
12.
go back to reference Bisharat N, Omari H, Lavi I et al (2001) Risk of infection and death among post-splenectomy patients. J Infect 43:182–186CrossRefPubMed Bisharat N, Omari H, Lavi I et al (2001) Risk of infection and death among post-splenectomy patients. J Infect 43:182–186CrossRefPubMed
13.
go back to reference Mourtzoukou EG, Pappas G, Peppas G et al (2008) Vaccination of asplenic or hyposplenic adults. Br J Surg 95:273–280CrossRefPubMed Mourtzoukou EG, Pappas G, Peppas G et al (2008) Vaccination of asplenic or hyposplenic adults. Br J Surg 95:273–280CrossRefPubMed
14.
go back to reference [No authors listed] (1996) Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. BMJ 312:430–434 [No authors listed] (1996) Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. BMJ 312:430–434
15.
go back to reference Davies JM, Barnes R, Milligan D (2002) Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med 2:440–443PubMed Davies JM, Barnes R, Milligan D (2002) Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med 2:440–443PubMed
16.
go back to reference Fuentes-Ferrer ME, Cano-Escudero S, Mato-Chaín G et al (2008) Vaccination coverage against Streptococcus pneumoniae in splenectomized patients in a fourth-level hospital (1999–2004). Enferm Infecc Microbiol Clin 26:194–198CrossRefPubMed Fuentes-Ferrer ME, Cano-Escudero S, Mato-Chaín G et al (2008) Vaccination coverage against Streptococcus pneumoniae in splenectomized patients in a fourth-level hospital (1999–2004). Enferm Infecc Microbiol Clin 26:194–198CrossRefPubMed
17.
go back to reference Hasse B, Moll C, Oehy K et al (2005) Anti-infectious prophylaxis after splenectomy: current practice in an eastern region of Switzerland. Swiss Med Wkly 135:291–296PubMed Hasse B, Moll C, Oehy K et al (2005) Anti-infectious prophylaxis after splenectomy: current practice in an eastern region of Switzerland. Swiss Med Wkly 135:291–296PubMed
18.
go back to reference Kyaw MH, Holmes EM, Chalmers J et al (2002) A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland. J Clin Pathol 55:472–474PubMed Kyaw MH, Holmes EM, Chalmers J et al (2002) A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland. J Clin Pathol 55:472–474PubMed
19.
go back to reference O’Donnell J, McGreal G, Daly P et al (2004) Management of patients undergoing splenectomy in an Irish teaching hospital: impact of guidelines. Ir J Med Sci 173:136–140CrossRefPubMed O’Donnell J, McGreal G, Daly P et al (2004) Management of patients undergoing splenectomy in an Irish teaching hospital: impact of guidelines. Ir J Med Sci 173:136–140CrossRefPubMed
20.
go back to reference Pickering J, Campbell H (2000) An audit of the vaccination and antibiotic prophylaxis practices amongst patients splenectomised in Lothian. Health Bull (Edinb) 58:390–395 Pickering J, Campbell H (2000) An audit of the vaccination and antibiotic prophylaxis practices amongst patients splenectomised in Lothian. Health Bull (Edinb) 58:390–395
21.
go back to reference Ramachandra J, Bond A, Ranaboldo C et al (2003) An audit of post-splenectomy prophylaxis—are we following the guidelines? Ann R Coll Surg Engl 85:252–255CrossRefPubMed Ramachandra J, Bond A, Ranaboldo C et al (2003) An audit of post-splenectomy prophylaxis—are we following the guidelines? Ann R Coll Surg Engl 85:252–255CrossRefPubMed
22.
go back to reference Musher DM, Ceasar H, Kojic EM et al (2005) Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J Infect Dis 191:1063–1067CrossRefPubMed Musher DM, Ceasar H, Kojic EM et al (2005) Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J Infect Dis 191:1063–1067CrossRefPubMed
23.
go back to reference Cherif H, Landgren O, Konradsen HB et al (2006) Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine 24:75–81CrossRefPubMed Cherif H, Landgren O, Konradsen HB et al (2006) Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine 24:75–81CrossRefPubMed
Metadata
Title
Management of post-splenectomy patients in the Netherlands
Authors
A. J. J. Lammers
D. Veninga
M. J. M. H. Lombarts
J. B. L. Hoekstra
P. Speelman
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0870-x

Other articles of this Issue 4/2010

European Journal of Clinical Microbiology & Infectious Diseases 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine